1 Ocak 2024 Dergi makalesi Açık Erişim

Bugdayci, Azimet Yalcin; Dizakar, Saadet Ozen Akarca; Demirel, Muerside Ayse; Omeroglu, Suna; Akar, Fatma; Uludag, Mecit Orhan

DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/284325</identifier>
  <creators>
    <creator>
      <creatorName>Bugdayci, Azimet Yalcin</creatorName>
      <givenName>Azimet Yalcin</givenName>
      <familyName>Bugdayci</familyName>
      <affiliation>Gazi Univ, Fac Pharm, Dept Pharmacol, Ankara, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Dizakar, Saadet Ozen Akarca</creatorName>
      <givenName>Saadet Ozen Akarca</givenName>
      <familyName>Dizakar</familyName>
      <affiliation>Bakircay Univ, Fac Med, Dept Histol &amp; Embryol, Izmir, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Demirel, Muerside Ayse</creatorName>
      <givenName>Muerside Ayse</givenName>
      <familyName>Demirel</familyName>
      <affiliation>Gazi Univ, Fac Pharm, Dept Basic Pharmaceut Sci, Ankara, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Omeroglu, Suna</creatorName>
      <givenName>Suna</givenName>
      <familyName>Omeroglu</familyName>
      <affiliation>Gazi Univ, Fac Med, Dept Histol &amp; Embryol, Ankara, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Akar, Fatma</creatorName>
      <givenName>Fatma</givenName>
      <familyName>Akar</familyName>
      <affiliation>Gazi Univ, Fac Pharm, Dept Pharmacol, Ankara, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Uludag, Mecit Orhan</creatorName>
      <givenName>Mecit Orhan</givenName>
      <familyName>Uludag</familyName>
      <affiliation>Near East Univ, TRNC, Dept Clin Pharm, Fac Pharm, Lefkosa, Turkiye</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Investigation Of The Relationship Between Inflammation And Microbiota In The Intestinal Tissue Of Female And Male Rats Fed With Fructose: Modulatory Role Of Metformin</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2024</publicationYear>
  <dates>
    <date dateType="Issued">2024-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/284325</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1007/s40199-024-00521-2</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">&lt;p&gt;Background It has been reported that High-Fructose (HF) consumption, considered one of the etiological factors of Metabolic Syndrome (MetS), causes changes in the gut microbiota and metabolic disorders. There is limited knowledge on the effects of metformin in HF-induced intestinal irregularities in male and female rats with MetS. Objectives In this study, we investigated the sex-dependent effects of metformin treatment on the gut microbiota, intestinal Tight Junction (TJ) proteins, and inflammation parameters in HF-induced MetS. Methods Fructose was given to the male and female rats as a 20% solution in drinking water for 15 weeks. Metformin (200 mg/kg) was administered by gastric tube once a day during the final seven weeks. Biochemical, histopathological, immunohistochemical, and bioinformatics analyses were performed. Differences were considered statistically significant at p &amp;lt; 0.05. Results The metformin treatment in fructose-fed rats promoted glucose, insulin, Homeostasis Model Assessment of Insulin Resistance Index (HOMA-IR), and Triglyceride (TG) values in both sexes. The inflammation score was significantly decreased with metformin treatment in fructose-fed male and female rats (p &amp;lt; 0.05). Moreover, metformin treatment significantly decreased Interleukin-1 Beta (IL-1 beta) and Tumor Necrosis Factor-Alpha (TNF-alpha) in ileum tissue from fructose-fed males (p &amp;lt; 0.05). Intestinal immunoreactivity of Occludin and Claudin-1 was increased with metformin treatment in fructose-fed female rats. HF and metformin treatment changed the gut microbial composition. Firmicutes/Bacteroidetes (F/B) ratio increased with HF in females. In the disease group, Bifidobacterium pseudolongum; in the treatment group, Lactobacillus helveticus and Lactobacillus reuteri are the prominent species in both sexes. When the male and female groups were compared, Akkermansia muciniphila was prominent in the male treatment group. Conclusion In conclusion, metformin treatment promoted biochemical parameters in both sexes of fructose-fed rats. Metformin showed a sex-dependent effect on inflammation parameters, permeability factors, and gut microbiota. Metformin has partly modulatory effects on fructose-induced intestinal changes.&lt;/p&gt;</description>
  </descriptions>
</resource>